3 ms·
> that a majority of pharmaceuticals are being produced in countries with lax regulatory controls The US FDA has an on-site presence in every major exporting c
by alephnerd 3y ago
> that a majority of pharmaceuticals are being produced in countries with lax regulatory controls
The US FDA has an on-site presence in every major exporting country to the US [0]
If I have a line of generic drugs I manufactured in India or China that I want to sell in the US, they will have to be tested by the FDA office in those countries in order to get past customs.
If those companies do not comply or break FDA regulations, they face US level fines and can even see valuations collapse [1]
[0] - https://www.fda.gov/about-fda/office-global-policy-and-strategy/office-global-operations https://www.fda.gov/about-fda/office-global-policy-and-strat...
[1] - https://www.reuters.com/business/healthcare-pharmaceuticals/indias-dr-reddys-shares-fall-observations-us-regulator-2023-12-11/ https://www.reuters.com/business/healthcare-pharmaceuticals/...
- toomuchtodo 3y agohttps://www.bloomberg.com/news/features/2023-12-05/pentagon-is-skeptical-of-cheap-generic-drugs-approved-by-the-fda https://www.bloomberg.com/news/features/2023-12-05/pentagon-... | https://archive.today/ubLmg https://archive.today/ubLmg ("The Pentagon Wants to Root Out Shoddy Drugs. The FDA Is In Its Way.") > They’ve saved taxpayers and consumers hundreds of billions of dollars a year. But recalls related to drug manufacturing quality doubled in the US from 2018 to 2022. With almost 80% of FDA-registered generic production facilities located overseas, years can pass between inspections. Profit margins on generics are so thin that there are often only one or two suppliers of vital medications. As a result, quality issues are fueling shocking shortfalls in supply, which a US Senate committee will examine on Tuesday. Shortages in the US reached near-record highs this year and left cancer patients, among others, waiting for life-saving treatments. Generics are supposed to be affordable and safe. Instead, they’re cheap — but sometimes dangerous. > Concern about the nation's drug supply has reached the point that big hospitals, the Defense Department and Congress are raising questions about the FDA's ability to monitor it. The Pentagon in August chose an independent lab with which the FDA has publicly feuded, Valisure LLC, to test some of the generics available to millions of military personnel and their families, two years after Kaiser Permanente, a health system serving 12.7 million in the US, started a similar program with the lab. > The efforts have run headlong into a major roadblock: the FDA itself. One might assume the US drug regulator, which dates to the 19th century Division of Chemistry, leads the mission of testing drugs. In fact, the FDA resists the idea of grading drugs by quality and rarely conducts tests of its own. Agency officials sought to block the Pentagon's nascent study, cast doubt on Valisure's methods and, according to multiple government officials, soured a Biden administration effort this year to introduce third-party testing more widely. I would be wary about trusting current FDA oversight and governance implementations overseas, especially in India due to geopolitical concerns (prioritizing the relationship over robust testing). The above piece dives into detail.
- alephnerd 3y ago> I would be wary about trusting current FDA oversight and governance implementations overseas, especially in India due to geopolitical concerns (prioritizing the relationship over robust testing). I have family that work in the Pharma Manufacturing Industry in India. If you've ever taken a generic drug, it's likely manufactured in a factory within 20 miles of my ancestral village. The US FDA does NOT compromise on testing in India and China. They will send US FDA inspectors to factories on random audits. There is stuff to complain about w/ regards to the US, but the US FDA is pretty good at safety globally. The only better regulatory agencies I can think of is the EU's EMA and SK's KFDA.
- iudqnolq 3y agoAs the article you're responding to details in one case FDA inspectors literally saw employees frantically destroying documents as they walked in. That factory was allowed to continue producing drugs. Empirical tests have shown certain factories manufactured drugs with insufficient concentration of the active ingredient. Those drugs are still on the market.
- alephnerd 3y agoValisure isn't a drug. It's regulated by the "Food Safety" division of the FDA. The FDA as an organization over-specializes on Biologics and Drug regulation at the expense of Food Regulation [0][1] and due to the "Food Safety" division's overlap with USDA. [0] - https://www.fda.gov/about-fda/fda-organization/fda-organization-charts https://www.fda.gov/about-fda/fda-organization/fda-organizat... [1] - https://www.politico.com/interactives/2022/fda-fails-regulate-food-health-safety-hazards/ https://www.politico.com/interactives/2022/fda-fails-regulat...
- iudqnolq 3y agoOf course Valisure isn't a drug. Valisure is the lab that tested the drug. What does that have to do wit- what I said?
- jqpabc123 3y agoIf those companies do not comply or break FDA regulations, they face US level fines and can even see valuations collapse [1] Ohhh scary !!! They circumvent this by simply setting up a privately held front company in New Jersey to be the importer of record. If the fines are minimal, they just pay them and continue business as usual. If the fines are too much or they run into PR issues that affect their business, they simply shut the front company down and start up a new one. In one particular case I have seen, the name of new company was the same as the old one but spelled backwards.
- alephnerd 3y ago> They circumvent this by simply setting up a privately held front company in New Jersey to be the importer of record. This is for Food, Supplements, Cosmetics, and other products that fall under the "Food Safety" Division For drugs and biologics, the regulations are much stricter after the fallout from the Ranbaxy scandal in 2013.
- jqpabc123 3y agothe regulations are much stricter after the fallout from the Ranbaxy scandal in 2013. And yet 10 years later, problems found with adulterated generic drugs and recalls are only increasing. January 2023 saw a significant increase in the number of drug recalls and units recalled compared to the Q4 2022 monthly average. https://www.pharmaceuticalprocessingworld.com/drug-recalls-2022-2023-contamination-sterility-concerns/ https://www.pharmaceuticalprocessingworld.com/drug-recalls-2...
- panarky 3y agoUnless the food or drug contains an ingredient or precursor that was manufactured in a third country, and that precursor was not shipped directly to the US. From the article quoting an FDA spokesperson: "We have limited authority over foreign ingredient suppliers that do not directly ship product to the US because their food undergoes further manufacturing/processing prior to export."